Derrick Sung - Mar 1, 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Financial Officer
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Derrick Sung
Stock symbol
LUNG
Transactions as of
Mar 1, 2022
Transactions value $
-$11,867
Form type
4
Date filed
3/3/2022, 05:14 PM
Previous filing
Dec 16, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$11.9K -458 -0.2% $25.91 225K Mar 1, 2022 Direct F1
transaction LUNG Common Stock Award $0 +31K +13.78% $0.00 256K Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +68.7K $0.00 68.7K Mar 1, 2022 Common Stock 68.7K $26.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.